• Return to Headlines

Recent 52-Week Low Surpassed in Shares of Immune Design In (IMDZ)

By James Quinn

Shares of Immune Design In (NASDAQ:IMDZ) traded today at $1.59, breaking its 52-week low. Approximately 1.1 million shares have changed hands today, as compared to an average 30-day volume of 188,000 shares.

Immune Design Corporation develops therapeutic vaccines. The Company creates synthetic compounds to boost the effectiveness of vaccines and technology designed to trigger a specific immune defense against viral and bacterial pathogens. Immune Design provides its products throughout the United States.

In the past 52 weeks, Immune Design In share prices have been bracketed by a current low of $1.59 and a high of $11.05 and are now at $1.59. Over the past week, the 200-day moving average (MA) has gone down 0.4% while the 50-day MA has declined 1.8%.

There is potential upside of 623.3% for shares of Immune Design In based on a current price of $1.59 and an average consensus analyst price target of $11.50. The stock should run into initial resistance at its 50-day moving average (MA) of $3.36 and subsequent resistance at its 200-day MA of $3.74.

SmarTrend is tracking the current trend status for Immune Design In and will alert subscribers who have IMDZ in their portfolio or watchlist when shares have changed trend direction.

Keywords: 52 week high/lows immune design in

Ticker(s): IMDZ